SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-001129
Filing Date
2018-02-28
Accepted
2018-02-28 08:00:38
Documents
3
Period of Report
2018-03-21
Effectiveness Date
2018-02-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2234672zdef14a.htm DEF 14A 125467
2 G29732BGI001.GIF g29732bgi001.gif GRAPHIC 85983
3 G29732BGI002.GIF g29732bgi002.gif GRAPHIC 111759
  Complete submission text file 0001047469-18-001129.txt   399195
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36020 | Film No.: 18648096
SIC: 2834 Pharmaceutical Preparations